Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug use: a Swedish population-based matched case-control study

Abstract

PurposeThis national, population-based study aims to determine the association between the number of prescribed medications and adverse drug events (ADE) by unintentional poisoning and examine this risk when known indicators of inappropriate drug use (IDU) are accounted for.MethodsWe employed a matched case-control design among people living in Sweden who were 50 years and older. Cases experiencing an ADE by unintentional poisoning resulting in hospitalization or death (n = 5336) were extracted from the National Health and Death Registers from January 2006 to December 2009. Four controls per case matched by age, sex and residential area were randomly selected among those without an ADE (n = 21,344). Prescribed medications dispensed during the 4-month period prior to the ADE were identified via the Swedish Prescribed Drug Register and coded according to the number of different dispensed medications (NDDM) (0 to 10 medications) and IDU indicators (one single-drug, and three drug-combinations). Conditional logistic regression was used.ResultsEach of the IDU indicators was significantly associated with very high risks of ADE. For NDDM, we found a lower but graded positive association from two to ten or more medications (adjusted OR, 1.5; 95% CI, 1.2–1.8). Exclusion of IDU from the NDDM decreased the risk of ADE, but the effects remained significant for three or more medications (adjusted OR excl. IDU, 1.5; 95% CI, 1.2–2.0).ConclusionAt population level, the number of different dispensed medications starting from three or more remains associated with ADE even after adjusting for known IDUs. Clinicians and patients need to be made aware of the increased likelihood of serious ADE, not only in case of documented inappropriate medications but also in the case of an increasing number of medications.Electronic supplementary materialThe online version of this article (doi:10.1007/s00228-017-2220-8) contains supplementary material, which is available to authorized users.

High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality

“…The identification of such distinct subgroups could be used to help target therapies and trials in heterogeneous syndromes such as ACHD. Clinical trials are prone to select patients without marked comorbidity, but concurrent use of different drugs is important to identify due to increased risk of drug–drug interactions and ADEs 26 , 27 . This may be most crucial in the comorbidity subgroup.…”

Chronic conditions and multimorbidity in a primary care population: a study in the Swiss Sentinel Surveillance Network (Sentinella)

“…However, another study is now investigating the reduction of inappropriate medication in multimorbid patients (Hasler et al 2015). A recent Swedish study by Rausch et al (2017) reported the total number of used drugs and inappropriate medication as associated with hospitalizations for unintentional poisoning.…”

Poly-De-prescribing vs Polypharmacy - The Weapon to Fight an Iatrogenic Epidemic: An Overview

“…However, this definition encompasses vast swathes of the population: 50% of Medicare beneficiaries receive five or more medications (31), as do 84% of older adults with cancer, 43% receive 10 medications or more (32). In my view, cutoff numbers should not be the main concern, since IMUP can occur with even a single medication and the risk of IMUP increases in a direct relationship with the number of medications prescribed (30,(33)(34)(35)(36). Given its futile nature, the time has come to close the door on the debate surrounding the definition of IMUP, and move the discourse decisively towards its effective treatment.…”